Gepants for Acute and Preventive Migraine Treatment: A Narrative Review.

Author: CapraraAna Letícia Fornari, RissardoJamir Pitton

Paper Details 
Original Abstract of the Article :
Calcitonin gene-related peptide (CGRP) antagonists are a class of medications that act as antagonists of the CGRP receptor or ligand. They can be divided into monoclonal antibodies and non-peptide small molecules, also known as gepants. CGRP antagonists were the first oral agents specifically design...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775271/

データ提供:米国国立医学図書館(NLM)

Gepants: A New Generation of Migraine Treatment

Migraines, a condition as unpredictable as a desert sandstorm, can be debilitating. This study, like a seasoned traveler with a well-stocked caravan, explores the potential of gepants, a new class of medication, in treating migraines. The researchers, like skilled pharmacists, review the efficacy and safety of gepants in both acute and preventive migraine treatment.

Gepants: A Promising New Avenue for Migraine Relief

The review suggests that gepants, like a refreshing oasis in a parched desert, offer a promising new approach for migraine management. The study highlights the effectiveness of gepants in reducing both acute and preventive migraine episodes, potentially offering a more tolerable and effective alternative to traditional treatments.

Navigating Migraine Relief: A Journey Towards Better Health

This research, like a beacon guiding travelers across a vast desert, provides valuable information for individuals seeking relief from migraines. The study's findings underscore the importance of continued research into new and innovative treatment strategies for migraines.

Dr.Camel's Conclusion

Gepants, a new class of migraine treatment, represent a potential breakthrough in addressing this debilitating condition. This research, like a map leading to a hidden oasis, offers hope for a better future for those living with migraines.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-12-25
Further Info :

Pubmed ID

36552072

DOI: Digital Object Identifier

PMC9775271

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.